Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
Year: 2020
Type: article
Source: The Lancet Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funder: University of Birmingham
OpenAlex ID: W3015151141
